Lewy body dementia: the litmus test for neuroleptic sensitivity and extrapyramidal symptoms.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Clinical Psychiatry

• Publication date

  2004-07-01

• Fields of study

  Medicine

• Identifiers
  PMID 15264967
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Use of atypical antipsychotic drugs in patients with dementia.

  2003cited by this paper
• Coma with accidental single dose of an atypical neuroleptic in a patient with Lewy Body dementia.

  2003cited by this paper
• MANAGEMENT OF PSYCHOSIS IN PARKINSON'S DISEASE

  2003influential reference
• Atypical antipsychotics in the EPS-vulnerable patient.

  2003cited by this paper
• Quetiapine treatment of psychotic symptoms and aggressive behavior in patients with dementia with Lewy bodies: a case series.

  2003cited by this paper
• The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementia

  2002influential reference
• Pharmacological Treatment of Psychosis and Agitation in Elderly Patients with Dementia

  2002cited by this paper
• Efficacy of Olanzapine in the Treatment of Psychosis in Dementia with Lewy Bodies

  2002influential reference
• Dopamine D3 and D4 receptor antagonists in the treatment of schizophrenia.

  2002cited by this paper
• Improvement of both psychotic symptoms and Parkinsonism in a case of dementia with Lewy bodies by the combination therapy of risperidone and L-DOPA.

  2002cited by this paper
• Quetiapine for psychosis in Parkinson's disease versus dementia with Lewy bodies.

  2002cited by this paper
• Probable Dementia with Lewy Bodies and Risperidone-Induced Delirium

  2002cited by this paper
• An algorithm (decision tree) for the management of Parkinson's disease (2001): Treatment guidelines

  2002cited by this paper
• An algorithm (decision tree) for the management of Parkinson's disease (2001): treatment guidelines.

  2001cited by this paper
• Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis.

  2001cited by this paper
• Efficacy and safety of clozapine and olanzapine: an open-label study comparing two groups of Parkinson's disease patients with dopaminergic-induced psychosis.

  2001cited by this paper
• Management of psychosis in Parkinson's disease

  2001cited by this paper
• MRI identification of early white matter injury in anoxic–ischemic encephalopathy

  2001cited by this paper
• Alzheimer's disease and related disorders.

  2001cited by this paper
• Review of quetiapine and its clinical applications in schizophrenia

  2000influential reference
• Olanzapine and clozapine

  2000cited by this paper
• Tolerability, efficacy and cognitive effects of quetiapine in patients with Parkinson's disease treated for psychotic symptoms

  2000cited by this paper
• The new generation of antipsychotic drugs: how atypical are they?

  2000cited by this paper
• Risperidone, neuroleptic malignant syndrome and probable dementia with Lewy bodies.

  2000cited by this paper
• Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds.

  2000cited by this paper
• Clozapine and risperidone treatment of psychosis in Parkinson's disease.

  2000cited by this paper
• Risperidone in the treatment of dopamine‐induced psychosis in Parkinson's disease: An open pilot trial

  2000cited by this paper
• Predictors of Nursing Home Placement in Parkinson's Disease: A Population‐Based, Prospective Study

  2000cited by this paper
• Treatment of dementia patients with psychotic and behavioural symptoms with quetiapine and donepezil

  2000cited by this paper
• Olanzapine in dementia with Lewy bodies: a clinical study

  1999cited by this paper
• Clozapine in dru g - i n d u c e d psychosis in Pa rk i n s o n 's disease

  1999cited by this paper
• Sensitivity and specificity of three clinical criteria for dementia with Lewy bodies in an autopsy‐verified sample

  1999cited by this paper
• Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease.

  1999cited by this paper
• Clozapine in drug-induced psychosis in Parkinson's disease. The French Clozapine Parkinson Study Group.

  1999cited by this paper
• Diffuse Lewy Body Disease: Clinical, Pathological, and Neuropsychological Review

  1999cited by this paper
• Quetiapine as an alternative to clozapine in the treatment of dopamimetic psychosis in patients with Parkinson's disease.

  1999cited by this paper
• An algorithm (decision tree) for the management of Parkinson's disease

  1998cited by this paper
• Diffuse Lewy body disease.

  1998influential reference
• Risperidol and withdrawal bruxism in Lewy body dementia

  1998cited by this paper
• Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer's disease

  1998influential reference
• Neuroleptic sensitivity to clozapine in dementia with Lewy bodies.

  1998cited by this paper
• Combination of risperidone and donepezil in Lewy body dementia.

  1998cited by this paper
• Quetiapine (Seroquel) in the treatment of psychosis in patients with Parkinson's disease.

  1998cited by this paper
• Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group.

  1997cited by this paper
• Drug treatment in Lewy body dementia.

  1997cited by this paper
• Psychiatric features in diffuse Lewy body disease

  1996cited by this paper
• Lewy body disease and dementia. A review.

  1996cited by this paper
• Brain mechanisms and psychotropic drugs

  1996cited by this paper
• Risperidone for psychotic and behavioural symptoms in Lewy body dementia.

  1995cited by this paper
• Neuroleptic sensitivity to risperidone in Lewy body dementia.

  1995cited by this paper
• Neuropsychiatric Manifestations of Diffuse Lewy Body Disease

  1995influential reference
• Clozapine use in diffuse Lewy body disease.

  1993cited by this paper
• Clozapine in the treatment of parkinsonian patients with dopaminomimetic psychosis

  1990cited by this paper
• Advances in Neuro‐oncology

  1990cited by this paper

• Compensatory hallucinogenesis across three neuropsychiatric disorders: a Bayesian account

  2026cites this paper
• [Clinical guidelines «Cognitive disorders in the elderly and senile persons»].

  2025cites this paper
• The use of NHS databases to identify and manage pharmacotherapy in people with dementia and/or late-life mental disorders

  2025cites this paper
• Loxapine for the treatment of psychosis in Lewy body dementia: A case report

  2025cites this paper
• New landscape of the diagnosis of Alzheimer's disease.

  2025cites this paper
• Right anterior insula ASL hypoperfusion as a diagnostic biomarker of prodromal and mild dementia with Lewy bodies: preliminary evidence using a Bayesian approach

  2024cites this paper
• Differences in Retinal and Choroidal Microvasculature and Structure in Dementia With Lewy Bodies Compared With Normal Cognition

  2023cites this paper
• 73-Year-Old Man With Altered Mental Status and Speech Difficulties.

  2023cites this paper
• Recent advances in Lewy body dementia: A comprehensive review.

  2022cites this paper
• Neuroleptic Sensitivity in Dementia with Lewy Body and Use of Pimavanserin in an Inpatient Setting: A Case Report

  2022cites this paper
• Valbenazine Treatment of Tardive Dyskinesia and of Positive Symptoms.

  2021cites this paper
• Genetic architecture of common non-Alzheimer’s disease dementias

  2020cites this paper
• Case Report: The Role of Neuropsychological Assessment and Imaging Biomarkers in the Early Diagnosis of Lewy Body Dementia in a Patient With Major Depression and Prolonged Alcohol and Benzodiazepine Dependence

  2020cites this paper
• Treatment of psychosis in Parkinson's disease and dementia with Lewy Bodies: A review.

  2020cites this paper
• Acute presentation of dementia with Lewy bodies.

  2019cites this paper
• Neuroleptic malignant syndrome as part of an akinetic crisis associated with sepsis in a patient with Lewy body disease

  2019cites this paper
• Dementia with Lewy Bodies

  2019cites this paper
• Dementia with Lewy Bodies

  2019cites this paper
• Meet Our Editorial Board Member

  2018cites this paper
• Forced Diuresis and Expedient Blood Pressure Control in the Management of Quetiapine Induced Neuroleptic Malignant Syndrome: A Case Report

  2018cites this paper
• Probable Lewy Body Dementia with a Predilection for Auditory Hallucinations

  2018cites this paper
• Pharmacotherapy in dementia with lewy bodies

  2017cites this paper
• Movements and Memory.

  2016cites this paper
• Neuroleptic Malignant Syndrome Caused by Quetiapine in an Elderly Man with Lewy Body Dementia

  2016influential citation
• Synucleinopathies: common features and hippocampal manifestations

  2016cites this paper
• Argyrophilic Grain Disease Presenting as Excited Catatonia: A Case Report.

  2016cites this paper
• Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Associated with Myeloma and Syndrome of Inappropriate Antidiuretic Hormone Secretion in an Elderly Man

  2016cites this paper
• Relationship between regional cerebral blood flow and neuropsychiatric symptoms in dementia with Lewy bodies

  2015cites this paper
• Molecular imaging biomarkers for dementia with Lewy bodies: an update

  2014cites this paper
• Antipsychotic use in elderly patients with dementia: Efficacy and safety concerns

  2014cites this paper
• The treatment of visual hallucinations at present and in the future

  2014cites this paper
• Cognitive effects of quetiapine in a patient with dementia with Lewy bodies

  2013cites this paper
• Characteristics of patients misdiagnosed with Alzheimer’s disease and their medication use: an analysis of the NACC-UDS database

  2013cites this paper
• An Overview of Dementias

  2012cites this paper
• Behavioral Disturbance in Dementia

  2012cites this paper
• Olanzapine-induced neuroleptic malignant syndrome in a patient with probable dementia with Lewy bodies.

  2012influential citation
• Consultation-Liaison Psychiatry and Prevention of Severe Neuroleptic Sensitivity Reactions in Dementia with Lewy Bodies

  2011cites this paper
• Dementia in Parkinson’s Disease

  2011cites this paper
• Dementia in Parkinson's

  2011cites this paper
• [Treatment of Lewy body dementia].

  2011cites this paper
• Health and Wellbeing of the Invisible: Homeless Women with Young Children

  2011cites this paper
• Dementia With Lewy Bodies

  2011cites this paper
• Symptoms of Dementia: A Review of the Evidence Pharmacological Treatment of Neuropsychiatric

  2010cites this paper
• (18)F-AV-133: A Selective VMAT2-binding Radiopharmaceutical for PET Imaging of Dopaminergic Neurons.

  2010cites this paper
• Treating Neuropsychiatric Symptoms in Dementia With Lewy Bodies: A Randomized Controlled-trial

  2010cites this paper
• Neuroleptic Sensitivity in the Elderly: Lesson from Clinical Practice

  2010cites this paper
• Converting from brand-name to generic clozapine: a review of effectiveness and tolerability data.

  2010cites this paper
• Recognizing dementia with Lewy bodies in older people

  2010cites this paper
• Aggression in persons with dementia: use of nursing theory to guide clinical practice.

  2009cites this paper
• Elevated serotonin transporter binding in depressed patients with Parkinson's disease: A preliminary PET study with [11C]DASB

  2008cites this paper
• Intact presupplementary motor area function in early, untreated Parkinson's disease

  2008cites this paper
• Themenschwerpunkt: Probleme der Pharmakotherapie bei der Demenz mit Lewy-Körperchen

  2008cites this paper
• Autonomic dysfunction in different subtypes of multiple system atrophy

  2008cites this paper
• Enfermedad con cuerpos de Lewy

  2008cites this paper
• Dementia in Parkinson's disease

  2008cites this paper
• Ultrasonographic findings of shoulder disorders in patients with Parkinson's disease

  2008cites this paper
• Subthalamotomy in cervical dystonia: A case study of lesion location and clinical outcome

  2008cites this paper
• Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6‐week, double‐blind, placebo‐controlled study

  2008cites this paper
• Cancer and blood concentrations of the comutagen harmane in essential tremor

  2008cites this paper
• Dementia with lewy bodies and charles bonnet syndrome.

  2008cites this paper
• Hemidystonia secondary to thalamic hemorrhage treated with GPi stimulation

  2008cites this paper
• Reversal of head drop after discontinuation of olanzapine in a DLB patient

  2008cites this paper
• GUIDEL INE FOR THE Treatment of Patients With Alzheimer ’ s Disease and Other Dementias

  2007cites this paper
• GUIDEL INE FOR THE Treatment of Patients With Alzheimer ’ s Disease and Other Dementias

  2007cites this paper
• Venlafaxine–lithium toxicity: suitability for use in the elderly

  2007cites this paper
• Presentation and management of psychosis in Parkinson's disease and dementia with Lewy bodies.

  2007cites this paper
• Antipsychotic Use among Older persons in Long-Term Institutional and Home Care

  2007cites this paper
• Donepezil for BPSD in dementia with Lewy bodies: a preliminary study

  2006cites this paper
• Management of aggression, agitation, and psychosis in dementia: Focus on atypical antipsychotics

  2006cites this paper
• Atypical antipsychotics to treat the neuropsychiatric symptoms of dementia

  2006cites this paper
• Quetiapine-induced neuroleptic malignant syndrome in dementia with Lewy bodies: a case report.

  2006cites this paper
• Neuroleptic drugs in dementia: benefits and harm

  2006cites this paper
• The role of conventional MR and CT in the work-up of dementia patients.

  2006cites this paper
• Effects of the traditional Chinese herbal medicine Yi-Gan San for cholinesterase inhibitor-resistant visual hallucinations and neuropsychiatric symptoms in patients with dementia with Lewy bodies.

  2005cites this paper
• Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence.

  2005cites this paper
• The role of conventional MR and CT in the work-up of dementia patients.

  2005cites this paper
• Diagnosis and Treatment of Alzheimer's Disease

  2005cites this paper
• Pharmacologic interventions for psychosis and agitation in neurodegenerative diseases: evidence about efficacy and safety.

  2005cites this paper
• Pharmacological Treatment of Neuropsychiatric Symptoms of Dementia

  2005cites this paper
• The relationship between antipsychotic treatment and quality of life for patients with dementia living in residential and nursing home care facilities.

  2004cites this paper